Huan Min

1.8k total citations · 1 hit paper
31 papers, 1.6k citations indexed

About

Huan Min is a scholar working on Biomedical Engineering, Molecular Biology and Oncology. According to data from OpenAlex, Huan Min has authored 31 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Biomedical Engineering, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Huan Min's work include Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (6 papers) and Clusterin in disease pathology (6 papers). Huan Min is often cited by papers focused on Nanoplatforms for cancer theranostics (11 papers), Nanoparticle-Based Drug Delivery (6 papers) and Clusterin in disease pathology (6 papers). Huan Min collaborates with scholars based in China, Australia and United States. Huan Min's co-authors include Guangjun Nie, Yinlong Zhang, Xuexiang Han, Yingqiu Qi, Yiye Li, Xiao Zhao, Ying Xu, Keman Cheng, Guangna Liu and Yao Li and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and Nano Letters.

In The Last Decade

Huan Min

26 papers receiving 1.6k citations

Hit Papers

Biomimetic Metal–Organic Framework Nanoparticles for Coop... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huan Min China 15 960 502 497 488 207 31 1.6k
Caina Xu China 24 1.2k 1.3× 695 1.4× 553 1.1× 732 1.5× 134 0.6× 33 2.0k
Yinying Pu China 21 1.1k 1.2× 476 0.9× 358 0.7× 578 1.2× 116 0.6× 29 1.6k
Wenjun Le China 17 839 0.9× 482 1.0× 440 0.9× 461 0.9× 106 0.5× 40 1.5k
Huige Zhou China 24 1.2k 1.2× 584 1.2× 674 1.4× 762 1.6× 147 0.7× 42 1.9k
Ludan Yue China 26 1.1k 1.2× 634 1.3× 745 1.5× 664 1.4× 107 0.5× 47 2.3k
Yuling Mao China 20 827 0.9× 350 0.7× 489 1.0× 552 1.1× 92 0.4× 42 1.4k
Kuikun Yang China 27 1.4k 1.5× 818 1.6× 801 1.6× 830 1.7× 112 0.5× 43 2.5k
Xinyi Lin China 21 718 0.7× 345 0.7× 373 0.8× 317 0.6× 98 0.5× 47 1.1k
Shiqun Shao China 20 1.3k 1.3× 852 1.7× 1.0k 2.1× 321 0.7× 209 1.0× 63 2.2k

Countries citing papers authored by Huan Min

Since Specialization
Citations

This map shows the geographic impact of Huan Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huan Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huan Min more than expected).

Fields of papers citing papers by Huan Min

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huan Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huan Min. The network helps show where Huan Min may publish in the future.

Co-authorship network of co-authors of Huan Min

This figure shows the co-authorship network connecting the top 25 collaborators of Huan Min. A scholar is included among the top collaborators of Huan Min based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huan Min. Huan Min is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bian, et al.. (2025). The pan-cancer analysis of LRG1 and its potential role in kidney renal clear cell carcinoma. RSC Medicinal Chemistry. 16(4). 1781–1796.
3.
Zhang, Jingjuan, Yongzheng Li, Furong Zhu, et al.. (2025). PROTAC based targeted degradation of LRG1 for mitigating corneal neovascularization. Journal of Controlled Release. 381. 113567–113567. 2 indexed citations
4.
Zhang, Jingjuan, Shiyu Song, Miao Xie, et al.. (2025). Inorganic nanomaterials as promising therapeutic agents for ocular neovascularization: Progress and perspectives. Materials Today Bio. 33. 102051–102051.
5.
Du, Lin, Huan Min, Yana Zhang, et al.. (2025). LRG1-Targeted Camptothecin Nanomicelles with Simultaneous Delivery of Olaparib for Enhanced Colorectal Cancer Chemotherapy. Nano Letters. 25(8). 3130–3140.
6.
Qi, Yingqiu, Yana Zhang, Hanqing Chen, et al.. (2025). Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 Degradation. ACS Nano. 19(28). 25645–25661. 2 indexed citations
7.
Zhang, Yana, Miaomiao Li, Aijun Zhang, et al.. (2024). Dehydrogenative α,γ-Diphosphinylation of Allylamines Enabled by Photoinduced Cobaloxime Catalysis. Organic Letters. 26(47). 10176–10182. 6 indexed citations
8.
Qi, Yingqiu, Xi Yang, Yana Zhang, et al.. (2024). Targeted degradation of LRG1 to attenuate renal fibrosis. Asian Journal of Pharmaceutical Sciences. 19(4). 100941–100941. 8 indexed citations
9.
Zhu, Furong, Tao Huang, Shengnan Du, et al.. (2023). Identification of LRG1 targeting peptide and its application in targeted imaging for breast cancer. Nano Research. 17(10). 9044–9051. 7 indexed citations
10.
Huang, Tao, Xiaofan Sun, Yingqiu Qi, et al.. (2023). Immunogenic cell death effects induced by doxorubicin improved chemo-immunotherapy via restoration of granzyme B activity. Nano Research. 16(12). 13250–13258. 10 indexed citations
11.
Qi, Yingqiu, Chen Liu, Hui Wang, et al.. (2023). Modularly designed peptide-based nanomedicine inhibits angiogenesis to enhance chemotherapy for post-surgical recurrence of esophageal squamous cell carcinomas. Nano Research. 16(5). 7347–7354. 5 indexed citations
12.
Qi, Yingqiu, Hui Wang, Chen Liu, et al.. (2022). Engineering Multifunctional Thylakoid as an Oxygen Self-Supplying Photosensitizer for Esophageal Squamous Cell Carcinoma-Targeted Photodynamic Therapy. CCS Chemistry. 5(11). 2519–2533. 9 indexed citations
13.
Min, Huan, Jing Wang, Yingqiu Qi, et al.. (2019). Biomimetic Metal–Organic Framework Nanoparticles for Cooperative Combination of Antiangiogenesis and Photodynamic Therapy for Enhanced Efficacy. Advanced Materials. 31(15). e1808200–e1808200. 356 indexed citations breakdown →
14.
Liu, Guangna, Xiao Zhao, Yinlong Zhang, et al.. (2019). Engineering Biomimetic Platesomes for pH‐Responsive Drug Delivery and Enhanced Antitumor Activity. Advanced Materials. 31(32). e1900795–e1900795. 199 indexed citations
15.
Xu, Ying, Xuexiang Han, Yiye Li, et al.. (2019). Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity. ACS Nano. 13(11). 13445–13455. 131 indexed citations
16.
Liu, Jiawei, et al.. (2018). Screening of neuraminidase inhibitory activities of some medicinal plants traditionally used in Lingnan Chinese medicines. BMC Complementary and Alternative Medicine. 18(1). 102–102. 24 indexed citations
17.
Lv, Qian, Huan Min, Dongban Duan, et al.. (2018). Total Aqueous Synthesis of Au@Cu2−xS Core–Shell Nanoparticles for In Vitro and In Vivo SERS/PA Imaging‐Guided Photothermal Cancer Therapy. Advanced Healthcare Materials. 8(2). e1801257–e1801257. 53 indexed citations
18.
Min, Huan, Jun Zhou, Xiao‐Jue Bai, et al.. (2017). Approach to Fabricating a Compact Gold Nanoparticle Film with the Assistance of a Surfactant. Langmuir. 33(27). 6732–6738. 6 indexed citations
19.
Son, Byung Ho, Laura S. Dominici, Fatih Aydoğan, et al.. (2015). Young Women with Breast Cancer in the United States and South Korea: Comparison of Demographics, Pathology and Management. Asian Pacific Journal of Cancer Prevention. 16(6). 2531–2535. 4 indexed citations
20.
Zu, Yanqun, et al.. (2014). Subcellular distribution and chemical form of Pb in hyperaccumulator Arenaria orbiculata and response of root exudates to Pb addition. Frontiers of Environmental Science & Engineering. 9(2). 250–258. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026